Sign In

Vijay Modur

Chief Medical Officer

Vijay Modur, M.D., Ph.D., is a highly accomplished physician-scientist who was recently appointed as Chief Medical Officer at BPGbio Inc., a leading AI-powered biopharma company focusing on oncology, neurology, and rare diseases.1

Professional Background

Dr. Modur brings over 25 years of experience as a drug developer to his new role at BPGbio.1 His career has been marked by significant contributions to the advancement of translational medicine and the development of novel therapeutics and diagnostics for various rare diseases.

Education and Certifications

  • Doctor of Philosophy (Ph.D.) from the University of Utah School of Medicine
  • Bachelor of Medicine (MBBS) from Karnataka University, Dharwad, India
  • Residency training in Pathology and Laboratory Medicine at Washington University in St. Louis
  • Board Certified in Clinical Pathology by the American Board of Pathology2

Previous Positions

Throughout his career, Dr. Modur has held several leadership positions in the pharmaceutical and biotech industries:

  • Head of Research and Development at Eloxx Pharmaceuticals
  • Chief Scientific and Medical Officer at Zikani Therapeutics
  • Global Project Head - Rare Disease Clinical Development at Sanofi Genzyme
  • Translational Medicine Lead at Sanofi Genzyme
  • Director, Clinical Research Physician at Novartis Oncology
  • Associate Director at Merck1

Expertise

Dr. Modur is known for his expertise in:

  • Rare disease clinical development
  • Translational medicine
  • Biomarker discovery
  • Diagnostic development
  • Clinical research
  • Drug pipeline advancement2

In his new role at BPGbio, Dr. Modur will continue to advance clinical trials and join the company's Leadership Team. His appointment comes as BPGbio plans for late-stage trials in oncology and rare diseases.1

Highlights

Jun 1 · linkedin

Biological networks are dynamic and highly malleable. AIs ability to decode biology is dependent on asking biological questions under relevant context to obtain actionable results. Having the right samples with sufficient annotation is key to asking the right biological questions that can be answered by advanced mathematical methods to apply to advance drug discovery and development. At BPGbio, Dr. Niven Narain has put understanding human biology at the center of the AI effort through rigorous annotation and analysis.

Related Questions

What are Vijay Modur's key achievements at Eloxx Pharmaceuticals?
How has Vijay Modur's work impacted the development of therapeutics for rare diseases?
What is the significance of Vijay Modur's role at BPGbio Inc?
Can you provide more details about Vijay Modur's experience at Sanofi Genzyme?
What are the main projects Vijay Modur is currently working on at BPGbio Inc?
V
Add to my network

Location

Greater Boston